The effect of sunitinib on biomarkers and tumor heterogeneity in metastatic clear cell renal cancer.
Grant Stewart(University of Edinburgh), Tom Powles(Queen Mary University of London), Alexander L. R. Lubbock(Institute of Genetics and Cancer), Ian M. Overton(Institute of Genetics and Cancer), David J. Harrison(NHS Lothian), Axel Bex(The Royal Free Hospital), Jyoti Nanda(Edinburgh Cancer Research), Alan Mackay(Institute of Cancer Research), Lél Eöry(University of Edinburgh), Daniel M. Berney(Queen Mary University of London), Alexander Laird(Pfizer (United States)), Peter Mullen(University of Southern California), Michael Aitchison(The Royal Free Hospital), Alan McNeill(University of Edinburgh), Marie O’Donnell(Birmingham Women’s and Children’s NHS Foundation Trust), Antony C. P. Riddick(Cambridge University Hospitals NHS Foundation Trust), Fiach C. O’Mahony(Edinburgh Cancer Research)
Cited by 2